Oncoimmunology., May 2015
Survivin-targeted Immunotherapy Drives Robust Polyfunctional T cell Generation and Differentiation in Advanced Ovarian Cancer Patients
Berinstein NL, Karkada M, Oza AM, Odunsi K, Villella JA, Nemunaitis JJ, Morse MA, Pejovic T, Bentley J, Buyse M, Nigam R, Weir GM, MacDonald LD, Quinton T, Rajagopalan R, Sharp K, Penwell A, Sammatur L, Burzykowski T, Stanford MM, Mansour M.
Vaccine, December 2014
Clearance of Depot Vaccine SPIO-labeled Antigen and Substrate Visualized Using MRI
Brewer KD, Lake K, Pelot N, Stanford MM, DeBay DR, Penwell A, Weir GM, Karkada M, Mansour M, Bowen CV.
OncoImmunology, November 2014
Metronomic Cyclophosphamide Enhances HPV16E7 Peptide Vaccine Induced Antigen-specific and Cytotoxic T-cell Mediated Antitumor Immune Response
Weir GM, Hrytsenko O, Stanford MM, Berinstein NL, Karkada M, Liwski RS, Mansour M.
ISRN Oncology, March 2013
Tumor Inhibition by DepoVax-based Cancer Vaccine is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor Infiltration
Karkada M, Quinton T, Blackman R, Mansour M.
J Trans Med., August 2012
First-in-man Application of a Novel Therapeutic Cancer Vaccine Formulation With the Capacity to Induce Multi-functional T Cell Responses in Ovarian, Breast and Prostate Cancer Patients
Berinstein NL, Karkada M, Morse MA, Nemunaitis JL, Chatta G, Kaufman H, Odunsi K, Nigam R, Sammatur L, MacDonald LD, Weir GM, Stanford MM, Mansour M.
Cancers, August 2011
Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccinations
Weir GM, Liwski RS, Mansour M.